AzTrials
AzTrials

Digital Shoulder RehabilitationNCT07301671

Prospective Cohort of Digital Shoulder Rehabilitation Using the REHABI System in Routine Clinical Practice

An observational study of Digital Shoulder Rehabilitation, run by Universidad Pública de Navarra at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is a prospective longitudinal observational cohort study of patients with shoulder disorders undergoing a standardized rehabilitation program supported by the REHABI digital automated model in a private physiotherapy clinic. Read more about this study

Who is it for?
Ages 18 to 71 years
Conditions the study is for
Digital Shoulder Rehabilitation
How many people
129 participants
Where
1 siteSpain
Study dates
17 Mar 2025to 29 Oct 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 71 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult patients with musculoskeletal shoulder pain treated in a private sports physiotherapy clinic in Pamplona, Spain, who are referred or self-referred for conservative management, consecutively enrolled in the REHABI digital rehabilitation program, and who have access to and basic skills to use a smartphone.

Who may be able to join

  • 18-71 years of age, acute non-traumatic shoulder pain/dysfunction, and access to a smartphone to view the exercises.

Who cannot join

  • Acute fractures or dislocations, arthritis/arthrosis, osteosarcoma, osteomyelitis, and recent shoulder surgeries.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Lorena Castaño de Egues

    Noáin, Navarre, 31110

Other trials in Spain

About this study

Official title: Prospective Longitudinal Observational Cohort Study of a Digital Automated Rehabilitation Model for Shoulder Disorders (REHABI) in a Private Physiotherapy Clinic

This is a prospective longitudinal observational cohort study of patients with shoulder disorders undergoing a standardized rehabilitation program supported by the REHABI digital automated model in a private physiotherapy clinic. The study aims to describe clinical outcomes in routine practice and to optimize a 24-test functional assessment battery based on deficit prevalence, magnitude, and responsiveness.

Read the detailed description

This is a prospective longitudinal observational cohort study of 129 adult patients (≥18 and ≤71 years) with acute non-traumatic shoulder pain and/or dysfunction treated in a private sports physiotherapy clinic in Pamplona, Spain. All patients undergo a standardized rehabilitation program supported by the REHABI automated digital model, which links quantified deficits obtained from a 24-test functional assessment battery to specific exercise prescriptions and progression rules. The study aims to describe clinical outcomes in routine practice (global clinical deficit score, shoulder pain intensity, number of treatment sessions, and days to discharge) and to optimize the initial 24-test battery based on deficit prevalence, magnitude, and responsiveness to change between baseline and discharge.

The main objectives are: (1) to evaluate the clinical effectiveness and feasibility of the REHABI model in routine clinical practice; and (2) to reduce the initial 24-test assessment battery to a smaller core set of tests using mixed criteria based on prevalence, magnitude of deficit, and responsiveness to change.

Keywords
Shoulder rehabilitation, digital physiotherapy, functional assessment, responsiveness (SRM), clinical effectiveness, Clinical automation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in global clinical deficit score from baseline to discharge

    Global clinical score summarizing the number and magnitude of positive findings in the functional test battery. Higher scores indicate greater functional deficit. Change is calculated as discharge score minus baseline score.

    Measured: Baseline and discharge (approximately 1-6 months after baseline, depending on clinical evolution)

Secondary outcomes (4)
  1. Change in selected functional tests from the optimized core battery

    Change in performance on selected shoulder functional tests (e.g., Yocum, Speed, Jobe, external rotation at 90° abduction, etc.) identified as part of the optimized core test battery.

    Measured: Baseline and discharge (ranging from 1 month to 6 month after baseline)

  2. Number of rehabilitation sessions until discharge

    Total number of physiotherapy sessions attended from baseline to discharge within the REHABI program.

    Measured: From baseline to discharge (approximately 1-6 months)

  3. Days from baseline to clinical discharge

    Number of days between the first assessment and the discharge visit recorded in the REHABI system.

    Measured: Baseline to discharge (ranging from 1 to 6 months)

  4. Change in shoulder pain intensity (Numeric Rating Scale, 0-10)

    Shoulder pain intensity during movement, measured using an 11-point Numeric Rating Scale (EVA 0-10). Change is calculated as discharge score minus baseline score.

    Measured: Baseline and discharge (approximately 1-6 months)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Dec 2025
  2. Study start17 Mar 2025
  3. Primary completion29 Oct 2025
  4. Study completion29 Oct 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
129 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07301671
Sponsor's protocol ID
1479272TES
Other IDs
0011-1408-2022-000012
Status last verified
Nov 2025
First submitted
26 Nov 2025
Last updated
24 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: At present, there is no plan to share individual participant data (IPD). This is a single-center study with a relatively small sample and detailed clinical assessments, which may increase the risk of re-identification, and the original informed consent did not explicitly cover broad IPD sharing. De-identified summary results will be available in the published manuscript, and additional aggregated information may be considered upon reasonable request.

Publications

  • Setuain I, Gonzalez-Izal M, Paularena A, Luque JL, Andersen LL, Izquierdo M. A protocol for a new methodological model for work-related shoulder complex injuries: From diagnosis to rehabilitation. BMC Musculoskelet Disord. 2017 Feb 7;18(1):70. doi: 10.1186/s12891-017-1435-2.

    PubMed 28173784
  • Castano L, Sanz J, Latasa I, Setuain I. Implementation, feasibility and optimization of a web- and mobile-supported semi-automated shoulder rehabilitation system (WMSSR): a prospective consecutive interventional cohort study. BMC Musculoskelet Disord. 2026 Jul 28;27(1):904. doi: 10.1186/s12891-026-10259-4.

    PubMed 42919177

Questions about this trial

What is this clinical trial studying?

An observational study of Digital Shoulder Rehabilitation, run by Universidad Pública de Navarra at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in global clinical deficit score from baseline to discharge (time frame: Baseline and discharge (approximately 1-6 months after baseline, depending on clinical evolution)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07301671, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in